Star Health and Allied Insurance Company Limited will host a virtual analyst meeting with Ellerston Capital on September 16, 2026, in Chennai. The one-to-one session is scheduled for 10:30 am.

The company issued the intimation on September 11, 2026, citing business exigencies that required shorter notice than usual. Star Health expressed regret for the delayed communication and committed to timely intimation for future engagements.

Meeting Details

The interaction will be conducted virtually. A presentation deck related to the meeting is available for download via the company’s official channels. The disclosure has been filed with both the BSE and NSE listing departments in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Jayashree Sethuraman, Company Secretary and Compliance Officer, signed the disclosure. The company noted that the schedule remains subject to change based on analyst or investor exigencies.

Star Health Insurance has declared the voting results for its 21st Annual General Meeting held on August 28, 2026. Shareholders approved the FY26 standalone financial statements and key board appointments through remote e-voting and poll voting.

The meeting, chaired by Non-Executive Independent Director Rajeev Kher, was conducted via video conferencing from Chennai. Members approved the reappointment of Deepak Ramineedi as a director and the appointment of Utpal Hemendra Sheth as a nominee director representing Sitara Partners LLP.

Voting Results Overview

A total of 498,698,497 votes were polled out of 588,623,619 shares held by 171,576 shareholders on the record date of August 21, 2026. This represents a 84.72% participation rate for the adoption of financial statements.

Resolution 1: Financial Statements

The ordinary resolution to adopt the audited standalone financial statements for the fiscal year ended March 31, 2026, received overwhelming support. Promoter group shareholders voted unanimously in favour. Public non-institutional shareholders also supported the resolution, with only 537 votes cast against it (0.0051%).

Resolution 2: Reappointment of Deepak Ramineedi

Deepak Ramineedi (DIN: 07631768), who retired by rotation, was reappointed as a director. The resolution received 99.59% support on votes polled. While promoter shareholders voted unanimously in favour, public institutional shareholders voted against the resolution at a rate of 1.25%.

Resolution 3: Appointment of Utpal Hemendra Sheth

Utpal Hemendra Sheth (DIN: 00081012) was appointed as a Non-Executive Nominee Director representing Sitara Partners LLP. This special resolution required promoter interest disclosure, which was marked as 'Yes'. The resolution passed with 97.61% support. Public institutional shareholders showed higher dissent here, voting against at a rate of 7.14%.

Management Participation

Managing Director and CEO Anand Roy addressed members alongside other key executives. The board participants included Chief Marketing Officer Himanshu Walia, Chief Operating Officer Amitabh Jain, and CFO Niles Kambli.

Independent directors Rohit Bhasin and Anisha Motwani were present in their respective committee chair capacities. Secretarial auditors from Chitra, Lalitha & Associates and scrutinizer Mirza Ismail Irshad Ahmed oversaw the voting process.